Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)49

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)28

Views

Views
February 20253
March 202514
April 20252
May 20251
June 20250
July 20258
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States4
Brazil4
Spain2
Argentina1
Austria1
Ecuador1
United Kingdom1
 

Top cities views

Views
Arroio Grande1
Buenos Aires1
Buffalo1
Council Bluffs1
Foz do Iguaçu1
Hartlepool1
Portoviejo1
Poté1
Renascença1
Valencia1